
Alert: New Earnings Report (2/24/25)-BioCryst Pharmaceuticals Inc (NASDAQ: BCRX).
For its fourth fiscal quarter (ending December 31), BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has reported a -58% decline in E.P.S. from $-0.31 a year ago to $-0.13 in the current quarter. For the latest four […]